Pyrophosphate    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
166Pseudoxanthoma elasticum4

166. Pseudoxanthoma elasticum    [ 11 clinical trials,   23 drugs,   (DrugBank: 6 drugs),   5 drug target genes,   26 drug target pathways]
Searched query = "Pseudoxanthoma elasticum", "PXE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
4 / 11 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04441671
(ClinicalTrials.gov)
December 8, 202020/1/2020Oral Pyrophosphate Absorption in PXE DiseaseOral Disodiumpyrophosphate (Na2H2PPi) Absorption in Pseudoxanthoma Elasticum (PXE)Pseudoxanthoma ElasticumDrug: Disodium PyrophosphateTampere University HospitalUMC Utrecht;Hungarian Academy of SciencesNot yet recruiting18 Years80 YearsAll12Phase 2NULL
2NCT04660461
(ClinicalTrials.gov)
February 4, 20203/12/2020Response to Oral Lansoprazole of Inorganic Pyrophosphate Levels in Patients With Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)Response to Oral Lansoprazole of Inorganic Pyrophosphate Levels in Patients With Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)Drug: Lansoprazole 30mg;Drug: PlaceboFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludNULLRecruiting18 YearsN/AAll20Phase 4Spain
3EUCTR2016-004021-16-ES
(EUCTR)
31/10/201810/03/2017Response to oral lansoprazole in patients with Pseudoxanthoma ElasticumResponse to oral lansoprazole in inorganic pyrophosphate levels in patients with Grönblad-Stranberg disease (Pseudoxanthoma Elasticum) - FIM-PXE-2016-01 Grönblad-Stranberg disease (Pseudoxanthoma Elasticum)
MedDRA version: 19.1;Level: PT;Classification code 10037150;Term: Pseudoxanthoma elasticum;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]
Trade Name: Lansoprazole
INN or Proposed INN: Lansolprazole
Other descriptive name: LANSOPRAZOLE
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
20Phase 2Spain
4EUCTR2018-001492-20-FI
(EUCTR)
20/06/201811/06/2018Pyrophosphate therapy in PXE diseasePseudoxanthoma elasticum – supplementation therapy of pyrophosphate deficiency Pseudoxanthoma elasticum;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]Trade Name: SODIUM ACID PYROPHOSPHATE
Product Name: SODIUM ACID PYROPHOSPHATE SAPP ROR 28 FOOD GRADE
Product Code: CAS No.: 7758-16-9
Tampere university hospitalNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
100Phase 2;Phase 3Finland